Stroke remains a potentially life-threatening disease despite recent advances in stroke management, including intravenous thrombolysis with recombinant tissue plasminogen activator [1] and endovascular therapy (thrombectomy and thrombolysis) for ischemic stroke [2]. The gene discussed is PLAT; the disease is Stroke.